Thuy V Tran
Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )
Most Active Art Unit | 2821 |
Art Unit(s) | 2821, 2844, 2856, 2814 |
Total Applications | 2202 |
Issued Applications | 1909 |
Pending Applications | 47 |
Abandoned Applications | 246 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16898971
[patent_doc_number] => 20210177887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING ELASTIC FIBER BREAKDOWN
[patent_app_type] => utility
[patent_app_number] => 17/185482
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185482 | COMPOSITIONS AND METHODS FOR TREATING ELASTIC FIBER BREAKDOWN | Feb 24, 2021 | Abandoned |
Array
(
[id] => 17035074
[patent_doc_number] => 20210252032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => DRUGS FOR GRP78 CELL SURFACE TRANSLOCATION AND PAR-4 SECRETION
[patent_app_type] => utility
[patent_app_number] => 17/178096
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178096 | Drugs for GRP78 cell surface translocation and Par-4 secretion | Feb 16, 2021 | Issued |
Array
(
[id] => 16870049
[patent_doc_number] => 20210163516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => Complexes
[patent_app_type] => utility
[patent_app_number] => 17/173500
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173500 | Complexes | Feb 10, 2021 | Issued |
Array
(
[id] => 16946554
[patent_doc_number] => 20210205245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => LIPOSOMAL ANTICANCER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/174291
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174291 | LIPOSOMAL ANTICANCER COMPOSITIONS | Feb 10, 2021 | Abandoned |
Array
(
[id] => 18232069
[patent_doc_number] => 11596611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Hepatitis B antiviral agents
[patent_app_type] => utility
[patent_app_number] => 17/166046
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43207
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166046
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166046 | Hepatitis B antiviral agents | Feb 2, 2021 | Issued |
Array
(
[id] => 17007040
[patent_doc_number] => 20210238201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/166138
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166138 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | Feb 2, 2021 | Pending |
Array
(
[id] => 16914019
[patent_doc_number] => 20210187111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOSITIONS AND METHODS FOR DISRUPTING A MACROPHAGE NETWORK
[patent_app_type] => utility
[patent_app_number] => 17/150703
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150703 | COMPOSITIONS AND METHODS FOR DISRUPTING A MACROPHAGE NETWORK | Jan 14, 2021 | Abandoned |
Array
(
[id] => 19368300
[patent_doc_number] => 12060370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Molybdenum (0) precursors for deposition of molybdenum films
[patent_app_type] => utility
[patent_app_number] => 17/146878
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6790
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146878 | Molybdenum (0) precursors for deposition of molybdenum films | Jan 11, 2021 | Issued |
Array
(
[id] => 18128814
[patent_doc_number] => 11555013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/139583
[patent_app_country] => US
[patent_app_date] => 2020-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 22390
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/139583 | Potent and selective inhibitors of monoamine transporters; method of making; and use thereof | Dec 30, 2020 | Issued |
Array
(
[id] => 16777994
[patent_doc_number] => 20210115072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Luminescent Metal Halide Perovskites and Methods
[patent_app_type] => utility
[patent_app_number] => 17/136288
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136288 | Luminescent metal halide perovskites and methods | Dec 28, 2020 | Issued |
Array
(
[id] => 16776437
[patent_doc_number] => 20210113514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => AMINOCARBONYLCARBAMATE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/136153
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136153 | AMINOCARBONYLCARBAMATE COMPOUNDS | Dec 28, 2020 | Abandoned |
Array
(
[id] => 16807718
[patent_doc_number] => 20210130271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES
[patent_app_type] => utility
[patent_app_number] => 17/123365
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17123365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/123365 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | Dec 15, 2020 | Abandoned |
Array
(
[id] => 16748813
[patent_doc_number] => 20210100822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => Synthetic Composition for Treating Antibiotic Associated Complications
[patent_app_type] => utility
[patent_app_number] => 17/120881
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17120881
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/120881 | Synthetic composition for treating antibiotic associated complications | Dec 13, 2020 | Issued |
Array
(
[id] => 17256867
[patent_doc_number] => 20210369852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHOD FOR IMPROVING SUBSTITUTION RATE AND/OR SUBSTITUTION EFFICIENCY OF HYALURONAN-DRUG CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/117231
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117231
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/117231 | Method for improving substitution rate and/or substitution efficiency of hyaluronan-drug conjugates | Dec 9, 2020 | Issued |
Array
(
[id] => 17124370
[patent_doc_number] => 20210299138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => Treating Hearing Loss
[patent_app_type] => utility
[patent_app_number] => 17/118111
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118111
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118111 | Treating Hearing Loss | Dec 9, 2020 | Pending |
Array
(
[id] => 16718358
[patent_doc_number] => 20210085505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => Compositions and Methods for Treating Severe Pain
[patent_app_type] => utility
[patent_app_number] => 17/113476
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/113476 | Compositions and methods for treating severe pain | Dec 6, 2020 | Issued |
Array
(
[id] => 18589220
[patent_doc_number] => 11738092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Methods and compositions for synthesis of therapeutic nanoparticles
[patent_app_type] => utility
[patent_app_number] => 17/112288
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23225
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112288 | Methods and compositions for synthesis of therapeutic nanoparticles | Dec 3, 2020 | Issued |
Array
(
[id] => 18996151
[patent_doc_number] => 11912983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Polyanionic acids to improve recovery and minimize system loss
[patent_app_type] => utility
[patent_app_number] => 17/112502
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 32
[patent_no_of_words] => 7768
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112502 | Polyanionic acids to improve recovery and minimize system loss | Dec 3, 2020 | Issued |
Array
(
[id] => 16710368
[patent_doc_number] => 20210077515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => COMPOSITIONS CONTAINING BETA-NICOTINAMIDE MONONUCLEOTIDE AND CORDYCEPS SINENSIS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/105563
[patent_app_country] => US
[patent_app_date] => 2020-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105563 | COMPOSITIONS CONTAINING BETA-NICOTINAMIDE MONONUCLEOTIDE AND CORDYCEPS SINENSIS AND USE THEREOF | Nov 25, 2020 | Abandoned |
Array
(
[id] => 16930805
[patent_doc_number] => 20210196694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => MUSCLE REGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/104192
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104192 | MUSCLE REGENERATION | Nov 24, 2020 | Abandoned |